Design, Synthesis and Biological Evaluation of Imidazole-Substituted/Fused Aryl Derivatives Targeting Tubulin Polymerization as Anticancer Agents

SynOpen

article

Kapil Kumar Goel¹  Satyendra Kumar Rajput¹  Rajeev Kharb² 

[1] Department of Pharmaceutical Sciences, Gurukul Kangri ,(Deemed to be University);Amity Institute of Pharmacy, Amity University

关键词: imidazoloquinoxalines;    anticancer agents;    tubulin;    imidazoles;    cytotoxicity;    cell division;    drug design;   

DOI  :  10.1055/s-0042-1751835

学科分类：精神健康和精神病学

来源: Thieme

【 摘 要 】

The development of new pharmacologically active molecules targeting tubulin polymerization has recently attracted great interest in research groups. In efforts to develop new potent anticancer compounds, imidazole-tethered/fused pharmacologically active aryl derivatives possessing different substitution patterns targeting tubulin polymerization have been rationally designed and synthesized. The target molecules (P1-5 and KG1-5) were synthesized by multistep syntheses involving the reaction of intermediate 2-aminophenyl-tethered imidazoles with appropriate reactants in the presence of p-TsOH under different conditions. The synthesized compounds displayed moderate to good cytotoxicity, comparable to that of colchicine, against four cancer cell lines (MCF-7, MD-MBA-231, A549, and HCT-116). Compounds P2 and P5, with an imidazoloquinoxaline moiety, emerged as potential leads with cytotoxicity profiles against these cell lines similar to colchicine. Compounds P2 and P5 arrested cell division at the G2/M phase and prevented cancerous cell growth through induced apoptosis. These results favored the hypothesis that the compounds might act by binding to the colchicine binding site, which was further confirmed with the help of a tubulin polymerization inhibition assay. The results encourage the further exploration of imidazoloquinoxalines as promising leads that deserve advanced clinical investigation.

【 授权许可】

CC BY|CC BY-NC-ND